ENDRA Life Sciences Inc. (NDRA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
5.75
-0.03 (-0.52%)
At close: Oct 03, 2025, 3:55 PM
5.72
-0.52%
After-hours: Oct 03, 2025, 07:29 PM EDT

ENDRA Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.23M 2.83M 4.89M 9.46M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
371.4K 3.26M 5.99K 5.99K
Receivables
n/a n/a n/a -1.35M
Inventory
n/a n/a 2.64M 1.28M
Other Current Assets
n/a n/a n/a 1.35M
Total Current Assets
3.43M 3.03M 8.53M 12.09M
Property-Plant & Equipment
647.29K 465.87K 741.47K 774.54K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.02M 3.72M 747.46K 780.53K
Total Assets
4.45M 6.75M 9.27M 12.87M
Account Payables
269.68K 360.4K 613.96K 791.05K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 28.48K 28.48K 132.33K
Other Current Liabilities
169.72K 148.79K 158.93K 269.46K
Total Current Liabilities
605.23K 903.1K 1.7M 1.54M
Long-Term Debt
n/a n/a n/a 28.48K
Other Long-Term Liabilities
799.28K n/a n/a n/a
Total Long-Term Liabilities
1.29M 192.06K 365.92K 546.63K
Total Liabilities
1.89M 1.1M 2.07M 2.09M
Total Debt
584.42K 394.4K 546.63K 678.96K
Book Value
2.56M 5.66M 7.2M 10.78M
Book Value Per Share
2.28 3.31 3.73 5.27
Common Stock
53.00 1.04K 317.00 4.25K
Retained Earnings
-103.44M -91.93M -81.87M -68.69M
Comprehensive Income
n/a 5.23K 6.07K 13.86K
Shareholders Equity
2.56M 5.66M 7.2M 10.78M
Total Investments
n/a n/a n/a n/a